Effectiveness of assertive community treatment versus care-as-usual for patients with severe and persistent psychiatric disorders
| ISRCTN | ISRCTN11281756 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN11281756 |
| Protocol serial number | NTR281; ZonMw: 100-103-016 |
| Sponsor | University Medical Centre Groningen (UMCG) (Netherlands) |
| Funder | The Netherlands Organisation for Health Research and Development (ZonMw) (Netherlands) |
- Submission date
- 20/12/2005
- Registration date
- 20/12/2005
- Last edited
- 03/07/2009
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr J.W. Bloemers
Scientific
Scientific
GGZ
P.O. Box 286
Winschoten
9670 AG
Netherlands
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised, active controlled, parallel group trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | |
| Study objectives | Assertive community treatment (ACT) will, compared to care-as-usual, result in less admission days and more sustained contact with mental health. Moreover, life skills will be more improved possibly resulting in a higher quality of life. |
| Ethics approval(s) | Received from the local medical ethics committee |
| Health condition(s) or problem(s) studied | Psychiatric, mental disorders/illness |
| Intervention | Assertive community treatment (ACT): in ACT the case load is a shared responsibility for the whole team. ACT is further characterised by: 1. A low staff-to-patient ratio (1 - 10 maximum) 2. In vivo treatment at home of the patient 3. The inclusion of a wide range of disciplines in the ACT team, including client participation Fidelity is measured by 28 items. |
| Intervention type | Other |
| Primary outcome measure(s) |
1. Admissions/admission days |
| Key secondary outcome measure(s) |
1. Psychiatric symptoms |
| Completion date | 31/08/2006 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target sample size at registration | 100 |
| Key inclusion criteria | Mental health patients with a Health of the Nation Scales (HoNOS) total score above 14 |
| Key exclusion criteria | Does not comply with the above inclusion criteria |
| Date of first enrolment | 01/09/2004 |
| Date of final enrolment | 31/08/2006 |
Locations
Countries of recruitment
- Netherlands
Study participating centre
GGZ,
Winschoten
9670 AG
Netherlands
9670 AG
Netherlands
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/08/2007 | Yes | No |
